WCN26-3296 SuPAR AND IgM-uria IMPROVES PREDICTION OF PROGRESSION OF EARLY CKD1-3. AN 8-YEAR FOLLOW-UP STUDY

Read full text Summarise with VIRAT
Authors: Omran Bakoush, Ali Al Dhanhani, Abderrahim Oulhaj, Hassan Abboudi, FATIMA AL AMERI, AYA BIN TALEB, Amal Khouri, May M.Y.H. Baniyas, Javed Yasin, Ghada Albluwi, Ahmad Alkrinat, Mohamed Ismail
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Chronic kidney disease (CKD) is associated with an increased risk of cardiovascular complications and kidney failure. In early-stage CKD (stages 1–3), standard clinical biomarkers such as estimated glomerular filtration rate (eGFR) and albuminuria may be less sensitive in assessing individual risk of kidney disease progression. Biomarkers of chronic inflammation, such as soluble urokinase plasminogen activator receptor (suPAR), and markers of glomerular capillary wall dysfunction, such as IgM-uria, may offer added value in improving CKD risk stratification.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Acute Kidney Injury Research Dialysis and Renal Disease Management

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104316–104316
Publication date
25 March 2026
Language
EN